Risiko
Bærekraft
🌳
🌳
🌳
(1 av 3)
Pris
1,43%
The Fund aims to achieve long-term capital growth. The Fund seeks to achieve its objective by investing primarily in equity and equity related securities of innovative healthcare companies throughout the world. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Investment Manager seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management.
10 største eierandeler
Eli Lilly and Co
8,9%
Boston Scientific Corp
7,9%
UnitedHealth Group Inc
6,7%
Intuitive Surgical Inc
5,6%
Invesco US Dollar Liqdty Port Agency
5,0%
Stryker Corp
4,3%
Danaher Corp
3,9%
Vertex Pharmaceuticals Inc
3,6%
AbbVie Inc
3,2%
Cencora Inc
2,5%
Helse
98,1%
Eiendom
1,9%
Nord-Amerika
89,0%
Europa
8,7%
Asia
2,3%
Tilgjengelig på kontotype
Med rebalansering
Uten rebalansering
Aksjesparekonto
Bedriftskonto
IPS
Pensjon
Dette koster fondet
Aksjesparekonto:
1,43 eller 1,53%*
Bedriftskonto:
1,43 eller 1,53%*
IPS:
1,43%
Pensjon:
1,43%
* Med rebalansering
Prisdetaljer
Pris for fondet:
1,93%
Plattformavgift:
0,25%
Returprovisjon:
-0,75%
(Eventuell rebalansering:
0,10%)
Vis priser med rabatt for Akademikerne Pluss eller Tekna
Avkastning pr. 07.05
Siste måned:
0,2%
Siste 6 måneder:
−11,0%
Hittil i år:
−8,9%
Siste år:
−8,8%
Siste 3 år (per år):
6,0%
Siste 5 år (per år):
3,6%
Morningstar-rating:
-
ISIN:
LU1775982595
Forvaltningskapital:
2 592 862 344 kr
Kategori:
-
NAV/Kurs (07.05.2025):
1 916 kr
Aksjer:
96,1%
Annet:
3,4%
Kontanter:
0,6%
Obligasjoner:
0,0%
Startdato:
07.09.2018